The Effectiveness of Physical Therapy at Home in Patients with Duchenne Muscular Dystrophy

The comparison of physiotherapy by parents at home and physiotherapy by expert physiotherapist in patients with Duchenne muscular dystrophy: Randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131012014988N7

Enrollment

Registered

2019-07-02

Start date

2019-05-22

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy. Muscular dystrophy

Interventions

Intervention group: Teaching Physical Therapy at Home to Parents or Patients - Physical Therapy At Home.

Eligibility

Sex/Gender

All

Age

No minimum to 15 Years

Inclusion criteria

Inclusion criteria: Patients with Duchenne muscular dystrophy who their clinical illness was confirmed by Biopsy and genetic test . alert parents between 18-50 years old informed consent live in north western in Iran

Exclusion criteria

Exclusion criteria: Patients that they dont live in North western of Iran or they Migrate No informed consent for participation or continuation of the study, they dont want to take part or don't have enough education.

Design outcomes

Primary

Measure	Time frame
Musculoskeletal pain (based on scores ranging from 0 to 10), the frequency of muscle cramps per week, muscle weakness in the four limbs with upper limb based on the international brooke score ( 1 to 6) and lower limbs based on the NSAA score ( 1 to 34 with 17 items). Timepoint: These parameters will be evaluated 2 times, 1- before the treatment and 2- six months after the treatment. Method of measurement: The upper limb muscle weakness score with the Brooke system and the lower muscle weakness score will be scored based on the NSAA system. The North Star Ambulatory Assessment (NSAA) has 17 items that can be used to assess motor ability in pediatric patients with duodenal muscular dystrophy. The highest score in this system is scoring 34, which means the ability to move completely independently. Brooke's Benchmarking Questionnaire uses 10 questions to evaluate muscular ability in the upper limb of patients with Duchenne's muscular dystrophy.	—

Measure

Time frame

Musculoskeletal pain (based on scores ranging from 0 to 10), the frequency of muscle cramps per week, muscle weakness in the four limbs with upper limb based on the international brooke score ( 1 to 6) and lower limbs based on the NSAA score ( 1 to 34 with 17 items). Timepoint: These parameters will be evaluated 2 times, 1- before the treatment and 2- six months after the treatment. Method of measurement: The upper limb muscle weakness score with the Brooke system and the lower muscle weakness score will be scored based on the NSAA system. The North Star Ambulatory Assessment (NSAA) has 17 items that can be used to assess motor ability in pediatric patients with duodenal muscular dystrophy. The highest score in this system is scoring 34, which means the ability to move completely independently. Brooke's Benchmarking Questionnaire uses 10 questions to evaluate muscular ability in the upper limb of patients with Duchenne's muscular dystrophy.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Barzegar

Tabriz University of Medical Sciences

phrc_mb@tbzmed.ac.ir+98 41 3337 2084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026